| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |